Exclusive: Moscow plans to use seized US-owned company to feed Russian army, document shows
LONDON, April 17 (Reuters) - Plans are afoot for an American-owned company seized by the Kremlin and placed under state control to be used to supply food to the Russian army, a document seen by Reuters showed, potentially threatening Moscow's warming relations with the U.S.
As the U.S. and the Kremlin negotiate to stop the war in Ukraine, the canned food maker Glavprodukt which was seized in October and is the only American-owned firm to be taken under state control, has been caught in the crosshairs.
U.S. Secretary of State Marco Rubio has said its treatment will be part of the conversation about resetting U.S.-Russia relations.
The seizure was necessary to ensure stable production, including for future supplies to the national guard and defence ministry, according to a letter, reviewed by Reuters, addressed to Russia's prosecutor general from Glavprodukt's new management.
Glavprodukt is now under the control of Russia's federal property management agency Rosimushchestvo having been seized from Los Angeles-based Leonid Smirnov.
Russia's industry and trade ministry and Rosimushchestvo did not respond to requests for comment on the state's plans for Glavprodukt and questions about its new management.
More: 'Everybody's to blame': Trump accuses Zelenskyy of starting Russia's war on Ukraine
Russian prosecutors have accused Smirnov and companies controlled by him of moving about 1.38 billion roubles ($17 million) out of Russia from 2022 to 2024, the RBC daily reported in March.
On March 12, Glavprodukt's assets were seized by the Moscow Arbitration Court at the request of the prosecutor general's office. A hearing is scheduled for April 18. Smirnov denies wrongdoing and says the lawsuit is a "Russian-style corporate raid" to steal his company.
The prosecutor general did not immediately respond to a request for comment.
About a dozen European companies have had their Russian subsidiaries expropriated by presidential decree, including Danish brewer Carlsberg and Finnish utility Fortum and the Kremlin has warned of more asset seizures.
The Ukraine invasion was expected to be a quick operation, but the war has now stretched to more than three years, seeing Russia hike defence spending and secure tighter control of strategic assets. In 2022, Russia was scrambling for military supplies, including food.
WHO STANDS TO GAIN FROM SEIZURE?
The letter reviewed by Reuters shines a light on the people standing to gain from the expropriation. It said that Rosimushchestvo appointed Glavprodukt's new director general at the request of food producer Druzhba Narodov.
Druzhba Narodov was the sole supplier to Russia's national guard for 2019-20, according to a 2018 press release.
A person familiar with the matter said that Glavprodukt never previously supplied Russia's army.
A 2018 investigation by late opposition politician Alexei Navalny's Anti-Corruption Fund revealed that then President Dmitry Medvedev had in 2017 signed off on Druzhba Narodov becoming the national guard's sole supplier.
Ownership information for Druzhba Narodov is classified, but Russian newspaper Kommersant reported in 2022, citing then publicly available information on Russia's EGRUL corporate registry, that entities connected to agriculture holding 'Agrocomplex named after N. I. Tkachev' had acquired Druzhba Narodov.
More: Kremlin says instant results not possible after Trump demands Ukraine progress
Reuters could not independently verify that as the information is now classified, but the Agrocomplex holding referred to, and Druzhba Narodov, share the same agrocomplex.ru domain name for some email addresses, according to their websites and filings from Russia's Spark corporate registry.
Druzhba Narodov and Agrocomplex did not respond to requests for comment.
The holding's ultimate owner is Alexander Tkachev, according to the company's 2025 independent audit filings, reviewed by Reuters.
Tkachev, sanctioned by the European Union in 2014 for his support of Moscow's annexation of Crimea, was appointed Russia's agriculture minister the following year, and is the holding company's board chairman, the filings show.
(Reporting by Anna Hirtenstein and Alexander Marrow in London;Editing by Elaine Hardcastle)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Post Heads West: New York Post Media Group Launches "The California Post"
New Los Angeles-Based Media Venture to Bring World Class Coverage and Indispensable Reporting to California NEW YORK, Aug. 4, 2025 /PRNewswire/ -- New York Post Media Group (NYPMG)—home of The New York Post, Page Six and Decider—is launching a new media venture, The California Post, in early 2026. The California Post will offer readers a unique and indispensable combination of fearless, common-sense journalism, celebrity and entertainment news, world class sports reporting and the legendary covers people expect from The New York Post—but from a distinctly Californian perspective. The California Post content will appear across multiple platforms and formats, including mobile and desktop sites, video, audio, social media and importantly, a daily print edition. The California Post will be headquartered in Los Angeles and staffed by a robust team of tenacious editors, reporters and photographers dedicated to covering the stories that matter most to the people who live and work in the Golden State. Across print, digital and social channels, the team will chronicle the incredible state of California—a global power center of culture, sports, business and politics. The California Post will also leverage NYPMG's national news gathering capabilities, sharing resources with The New York Post and adding even more value for readers. This new venture is launching at the right time for NYPMG, California and Los Angeles. The Post brand, influence and reach has never been stronger, with The Post Digital Network, which includes and attracting 90 million unique visitors in June alone. Ninety percent of Post digital readers already live outside of the New York media market. Los Angeles is home to the second largest concentration of Post readers, with 3.5 million monthly unique visitors—and 7.3 million across the state. This new masthead further positions The Post as a true national brand, substantially increasing its profile on the West Coast. The New York Post has achieved three consecutive years of profitability beginning in Fiscal Year 2022, an impressive achievement in a challenging environment for some publishers. NYPMG has appointed News Corp veteran Nick Papps as The California Post's Editor-in-Chief. Papps has nearly two decades of editorial leadership, and has helped drive editorial and commercial success at multiple publications. He has also served as News Corp Australia's West Coast Correspondent for nearly three years and was based in Los Angeles. Now more than ever, Californians need a media outlet dedicated to common sense, clever coverage of the most important issues, many of which are ignored or dismissed by current print and digital outlets. Despite its vibrancy—as well as the upcoming Olympic Games and World Cup—California lacks a voice that will hold leaders to account as they attempt to tackle the most critical issues facing residents. In fact, Los Angeles is fast becoming a news desert, despite being home to nearly 13 million monthly digital news readers. Thousands of stories are going untold and countless perspectives aren't being represented by a media ecosystem that has lost touch with the people—especially as the city and state face unprecedented challenges and leadership vacuums. Perhaps that's why The New York Post already outranks the leading LA-based publication when it comes to desktop viewership according to Comscore, and is gaining ground in every corner of the state. "Los Angeles and California surely need a daily dose of The Post as an antidote to the jaundiced, jaded journalism that has sadly proliferated. We are at a pivotal moment for the city and the state, and there is no doubt that The Post will play a crucial role in engaging and enlightening readers, who are starved of serious reporting and puckish wit," said News Corp Chief Executive Robert Thomson. "I am also pleased that Keith Poole's remit is expanding, as he will now be responsible for covering not just New York, but California, the U.S., the world and, perhaps, Mars." "This is the next manifestation of our national brand," said Keith Poole, Editor-in-Chief of The New York Post. "California is the most populous state in the country, and is the epicenter of entertainment, the AI revolution and advanced manufacturing—not to mention a sports powerhouse. Yet many stories are not being told, and many viewpoints are not being represented. With The California Post, we will bring a common-sense, issue-based approach to metropolitan journalism. We'll tell the stories that our readers care about the most, but others overlook, and we'll do so with clarity and our trademark conviction, across print, digital and the platforms where audiences live today. "I am also thrilled to welcome Nick Papps to The Post family," continued Poole. "Nick has a keen sense for the stories that matter, an understanding of what makes Los Angeles tick and the ability to apply The Post's unique voice to this vibrant market." "Our content is read everywhere from the corner store to the corner office," added Sean Giancola, CEO of New York Post Media Group. "We are trusted by millions for our direct and plain-spoken approach to news, and The New York Post has been the voice of the people in New York for 200 years. California is a vibrant, dynamic market where our unique journalistic ethos will resonate and engage audiences in meaningful ways." The California Post will operate as a separate entity under the New York Post Media Group and will launch in early 2026. If you are a reporter, editor or audience development professional, especially in the Los Angeles area, and looking for an opportunity to have an impact in the state of California, the team is in the process of staffing its LA-based operations. If you are interested in applying for a role at The California Post, please visit the New York Post Media Group's Careers site: About New York Post Media GroupNew York Post Media Group is home to the oldest continuously-published daily newspaper in the United States, The New York Post, founded by Alexander Hamilton in 1801. Its portfolio also houses some of the nation's premier digital destinations for news, sports and entertainment, including The California Post and fabled Page Six gossip column, a world leader in breaking celebrity news that has evolved into its own iconic and powerful brand. The Post Digital Network is composed of the flagship including Page Six Style, and covering streaming television and movies. The New York Post Media Group is owned by News Corp (Nasdaq: NWS, NWSA; ASX: NWS, NWSLV). View original content: SOURCE The New York Post
Yahoo
8 minutes ago
- Yahoo
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
8 minutes ago
- Yahoo
The jobs data revisions that cost a US government statistician her job
(Reuters) -The revisions to previous estimates of the size of U.S. payrolls gains for May and June that prompted President Donald Trump to fire Bureau of Labor Statistics Commissioner Erika McEntarfer on Friday were by any measure extraordinarily large. Indeed, the combined downward revision for the two months of 258,000 was the largest - outside of those during the early months of the COVID-19 pandemic - since at least 1979. Here's a quick graphical breakdown: FIRST REVISION The monthly nonfarm payrolls report, released typically on the first Friday of each month, includes an initial estimate of employment changes for the immediately preceding month and revisions to the earlier estimates for the prior two months. BLS makes the revisions because more survey responses come in over the ensuing weeks and because it updates the seasonal factors affecting each month's estimates. The BLS on Friday said 133,000 fewer jobs had been created in June than first estimated. Over the last several years, the first estimate of the net change in payrolls each month has been revised lower more often than not. It has been revised down in eight of the last 12 BLS reports over the last year. The downward revision on Friday was the largest since the first estimate of payrolls gains for March 2021, published in April 2021, was revised down by 146,000 a month later. Over the last three years through June, the median estimate revision was -10,000. That contrasts with a median increase of 8,000 during the decade before the pandemic and a median increase of 2,000 over the series history since 1979. SECOND REVISION The total for May's payroll gains was revised lower by 125,000 in Friday's report, when the third estimate for payrolls for that month was published. That figure was the largest downward reduction of payrolls gains for a second revision - outside of the pandemic era - since the estimate for March 1983 was revised down by 127,000 in the report published in June 1983. COMBINED REVISION The combined downward revision for the two previous months - May and June - was larger than anything reported outside of the pandemic era. Indeed, the estimates for the two prior months combined have more often than not been revised higher. Since 1979, the median two-month combined estimate change was an upward revision of 10,000. Measured in absolute terms - revisions in either direction - Friday's revision also stands out. There have only been four larger revisions: +709,000 for November and December 2021; -642,000 for March and April 2020; +285,000 for August and September 1983; and +414,000 for April and May 1981. Solve the daily Crossword
